Support
| 2016-2018 |
Neuroprotective effects of novel analogs of anorexigenic prolactin-releasing peptide (PrRP)
Grant agency of the Czech Republic (16-00918S) |
| 2012-2019 |
Center for development of original drugs (CCOD)
Technology Agency of the Czech Republic (TE01020028) |
| 2015-2017 |
The possible role of stable analogs of prolactin-releasing peptide in experimental models of obesity and hypertension
Grant agency of the Czech Republic (15-08679S) |
| 2013-2016 |
Metabonomics of mouse models of obesity and lipoatrophy - studies of metabolic pathways perturbations, disease progression and therapy response
Grant agency of the Czech Republic (13-14105S) |
| 2012-2014 |
Effect of different types of antidiabetic interventions on the development of neurodegenerative changes in brain of diabetic mice
Grant agency of the Czech Republic (P303-12-0576) |
| 2010-2013 |
New pharmacological interventions influencing energy homeostasis and development of insulin resistance/ type 2 diabetes mellitus
Grant agency of the Czech Republic (303/10/1368) |
| 2009-2011 |
Impact of hypothalamic-pituitary-gonadal (HPG) axis on food intake regulation in female obese mice
Grant agency of the Czech Republic (303/09/0744) |
| 2005-2007 |
Central and peripheral effects of CART (cocaine- and amphetamine-regulated transcript) related to food intake
Grant agency of the Czech Republic (303-05-0614) |